143 related articles for article (PubMed ID: 8362424)
1. Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction.
Houkin K; Kamada K; Kamiyama H; Iwasaki Y; Abe H; Kashiwaba T
Stroke; 1993 Sep; 24(9):1316-21. PubMed ID: 8362424
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in patients with ischemic stroke.
Federico F; Conte C; Simone IL; Giannini P; Liguori M; Picciola E; Tortorella C; Ferrari E
Ital J Neurol Sci; 1994 Nov; 15(8):413-20. PubMed ID: 7875959
[TBL] [Abstract][Full Text] [Related]
3. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy.
Saunders DE; Howe FA; van den Boogaart A; McLean MA; Griffiths JR; Brown MM
Stroke; 1995 Jun; 26(6):1007-13. PubMed ID: 7762015
[TBL] [Abstract][Full Text] [Related]
4. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging.
Lanfermann H; Kugel H; Heindel W; Herholz K; Heiss WD; Lackner K
Radiology; 1995 Jul; 196(1):203-10. PubMed ID: 7784568
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy in the evaluation of children with congenital heart disease and acute central nervous system injury.
Ashwal S; Holshouser BA; Hinshaw DB; Schell RM; Bailey L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):403-14. PubMed ID: 8751509
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy.
Gideon P; Sperling B; Arlien-Søborg P; Olsen TS; Henriksen O
Stroke; 1994 May; 25(5):967-73. PubMed ID: 8165692
[TBL] [Abstract][Full Text] [Related]
7. Early temporal variation of cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study.
Graham GD; Blamire AM; Rothman DL; Brass LM; Fayad PB; Petroff OA; Prichard JW
Stroke; 1993 Dec; 24(12):1891-6. PubMed ID: 8248973
[TBL] [Abstract][Full Text] [Related]
8. 99Tcm-HMPAO SPET and 1H-MRS (proton magnetic resonance spectroscopy) in patients with ischaemic cerebral infarction.
Lauriero F; Federico F; Rubini G; Conte C; Simone I; Inchingolo V; d'Addabbo A
Nucl Med Commun; 1996 Feb; 17(2):140-6. PubMed ID: 8778638
[TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
[TBL] [Abstract][Full Text] [Related]
10. Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy.
Wang Z; Bogdan AR; Zimmerman RA; Gusnard DA; Leigh JS; Ohene-Frempong K
Neuroradiology; 1992; 35(1):57-65. PubMed ID: 1289741
[TBL] [Abstract][Full Text] [Related]
11. Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans.
Fenstermacher MJ; Narayana PA
Invest Radiol; 1990 Sep; 25(9):1034-9. PubMed ID: 2211046
[TBL] [Abstract][Full Text] [Related]
12. Human brain infarction: proton MR spectroscopy.
Duijn JH; Matson GB; Maudsley AA; Hugg JW; Weiner MW
Radiology; 1992 Jun; 183(3):711-8. PubMed ID: 1584925
[TBL] [Abstract][Full Text] [Related]
13. In vivo relaxation of N-acetyl-aspartate, creatine plus phosphocreatine, and choline containing compounds during the course of brain infarction: a proton MRS study.
Gideon P; Henriksen O
Magn Reson Imaging; 1992; 10(6):983-8. PubMed ID: 1461096
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease.
Bowen BC; Block RE; Sanchez-Ramos J; Pattany PM; Lampman DA; Murdoch JB; Quencer RM
AJNR Am J Neuroradiol; 1995 Jan; 16(1):61-8. PubMed ID: 7900603
[TBL] [Abstract][Full Text] [Related]
15. [Longitudinal change of H-1 spectroscopy in cerebral infarction].
Houkin K; Matsuzawa H; Miyasaka K; Kamiyama H; Iwasaki Y; Abe H; Hida K; Koiwa M; Kashiwaba T
No To Shinkei; 1991 Jun; 43(6):583-7. PubMed ID: 1910941
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy of brain in congenital myotonic dystrophy.
Hashimoto T; Tayama M; Yoshimoto T; Miyazaki M; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
Pediatr Neurol; 1995 May; 12(4):335-40. PubMed ID: 7546006
[TBL] [Abstract][Full Text] [Related]
17. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study.
Gideon P; Henriksen O; Sperling B; Christiansen P; Olsen TS; Jørgensen HS; Arlien-Søborg P
Stroke; 1992 Nov; 23(11):1566-72. PubMed ID: 1440704
[TBL] [Abstract][Full Text] [Related]
18. Cerebral lactate and N-acetyl-aspartate/choline ratios in asphyxiated full-term neonates demonstrated in vivo using proton magnetic resonance spectroscopy.
Groenendaal F; Veenhoven RH; van der Grond J; Jansen GH; Witkamp TD; de Vries LS
Pediatr Res; 1994 Feb; 35(2):148-51. PubMed ID: 8165047
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy in acute middle cerebral artery stroke.
Gillard JH; Barker PB; van Zijl PC; Bryan RN; Oppenheimer SM
AJNR Am J Neuroradiol; 1996 May; 17(5):873-86. PubMed ID: 8733962
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy.
Sibbitt WL; Haseler LJ; Griffey RH; Hart BL; Sibbitt RR; Matwiyoff NA
AJNR Am J Neuroradiol; 1994 May; 15(5):923-8. PubMed ID: 8059662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
